Le, Kai <br/><br/>
SIRT1-regulated HMGB1 release is partially involved in TLR4 signal transduction: A possible anti-neuroinflammatory mechanism of resveratrol in neonatal hypoxic-ischemic brain injury.  [electronic resource] 

 -  International immunopharmacology  Oct 2019 
 - 105779 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2019.105779  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Anti-Inflammatory Agents--pharmacology<br/>Brain--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cytokines--genetics<br/>Female<br/>HMGB1 Protein--immunology<br/>Hypoxia-Ischemia, Brain--drug therapy<br/>Mice, Inbred ICR<br/>Microglia--drug effects<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Resveratrol--pharmacology<br/>Signal Transduction--drug effects<br/>Sirtuin 1--immunology<br/>Toll-Like Receptor 4--immunology